RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
105.000 |
Evidence |
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
105.000 |
Evidence |
O
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
105.000 |
Evidence |
O
|
POLR1C |
POLR1C, POLR1E: DNA-directed RNA polymerases I and III subunit RPAC1 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
105.000 |
Evidence |
O
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
105.000 |
Evidence |
|
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
105.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
105.000 |
Evidence |
O
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
105.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
DOK1 |
DOK1: Docking protein 1 |
105.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
105.000 |
Evidence |
|
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
105.000 |
Evidence |
|
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
105.000 |
Evidence |
O
|
HBZ |
HBZ, HBZ2: Hemoglobin subunit zeta |
HBZ |
HBA1, HBA2: Hemoglobin subunit alpha |
105.000 |
Evidence |
|
CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
105.000 |
Evidence |
O
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
CTRC |
CTRC, CLCR: Chymotrypsin-C precursor |
105.000 |
Evidence |
|
CPA2 |
CPA2: Carboxypeptidase A2 precursor |
CTRC |
CTRC, CLCR: Chymotrypsin-C precursor |
105.000 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
104.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
104.000 |
Evidence |
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
104.000 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|